Rhinitis Medicamentosa: Therapeutic Effect of Diode Laser Inferior Turbinate Reduction on Nasal Obstruction and Decongestant Abuse
- 1 July 2008
- journal article
- research article
- Published by SAGE Publications in American Journal of Rhinology
- Vol. 22 (4) , 433-439
Abstract
Background: The purpose of this study was to evaluate long-term outcomes of an outpatient-based diode laser inferior turbinate reduction (ITR) in therapy-refractory rhinitis medicamentosa (RM). Methods: In a prospective clinical investigation, 42 consecutive RM patients underwent videoendoscopic ITR with a diode laser after topical anesthetic preparation. Intra- and perioperative details were recorded including the occurrence of bleeding, crusting, pain, or discomfort. Treatment efficiency was assessed by follow-ups 1 and 6 weeks as well as 6 and 12 months after surgery. Subjective pre- and posttherapeutic nasal airflow (NA) and patient satisfaction were rated on visual analog scales (VASs). Assessment of the long-term objective clinical effectiveness was based on rhinomanometry, IT photodocumentation, and the recurrent need for decongestants. Results: Preoperative addiction to decongestants lasted 5 ± 2 years (mean ± SD). There was no major bleeding requiring nasal packing, and there were no other perioperative complications. Postoperative edema disappeared within the 1st week and crusting within 6 weeks after surgery. VAS was characterized by very low values for intraoperative pain and discomfort and high postoperative patient satisfaction. After 6 months, NA data revealed a significant improvement of subjective VAS and objective rhinomanometry (250.4–413.9 cm 3 /s inspiration at 150 Pa). A total of 88% of patients managed to successfully stop decongestant abuse after 6 months (74% after 1 year). Conclusion: In therapy-refractory RM, outpatient diode laser ITR of hyperplastic IT represents a highly effective, safe, and well-tolerated treatment option that provides long-lasting recovery by markedly improving NA and stopping addiction to nasal decongestants.Keywords
This publication has 23 references indexed in Scilit:
- Comparison of long term results after Ho:YAG and diode laser treatment of hyperplastic inferior nasal turbinatesLasers in Surgery and Medicine, 2007
- Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of useExpert Opinion on Drug Safety, 2006
- Use of Mometasone Furoate Aqueous Nasal Spray in the Treatment of Rhinitis Medicamentosa: An Experimental StudyOtolaryngology–Head and Neck Surgery, 2005
- Surgical treatment of the inferior turbinate: new techniquesCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2004
- Laser treatment of hyperplastic inferior nasal turbinates: A reviewLasers in Surgery and Medicine, 2001
- Reliable and reproducible anterior active rhinomanometry for the assessment of unilateral nasal resistanceClinical Otolaryngology, 2000
- An Evaluation of Nasal Response following Different Treatment Regimes of Oxymetazoline with Reference to Rebound CongestionAmerican Journal of Rhinology, 1997
- Extended Use of Topical Nasal DecongestantsThe Laryngoscope, 1997
- One Year follow-up of Patients with Rhinitis Medicamentosa after Vasoconstrictor WithdrawalAmerican Journal of Rhinology, 1997
- Sustained Use of Xylometazoline Nose Drops Aggravates Vasomotor RhinitisAmerican Journal of Rhinology, 1991